openPR Logo
Press release

Menkes Disease Market and Epidemiology Forecast 2032: Population Data, Drugs, Companies and Competitive Intelligence by DelveInsight | Cyprium Therapeutics

10-13-2023 01:54 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Menkes Disease Market and Epidemiology Forecast 2032:

DelveInsight's "Menkes Disease Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Menkes Disease, historical and forecasted epidemiology as well as the Menkes Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Menkes Disease market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Menkes Disease Market Forecast
https://www.delveinsight.com/sample-request/menkes-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Menkes Disease Market Report:
• The Menkes Disease market size was valued approximately USD 0.2 million in 2021 and is anticipated to grow with a significant CAGR during the study period (2019-2032)
• Menkes Disease was determined to have 156 total diagnosed prevalent cases in the 7MM as of 2021, and this number is projected to rise at a compound annual growth rate (CAGR) of 7.60% during the course of the study
• With 79 cases in 2021, or 51% of all confirmed prevalent cases in 7MM, the United States had the most Menkes Disease cases that were diagnosed as being prevalent
• France had the greatest diagnosed prevalence of Menkes Disease among the European nations in 2021, with 15 cases, followed by Germany and the UK, each with 14 cases. Spain, however, has the lowest diagnosed prevalence rate
• Key Menkes Disease Companies: Cyprium Therapeutics Inc., and others
• Key Menkes Disease Therapies: Copper Histidinate, and others
• The Menkes Disease epidemiology based on gender analyzed that Menkes Disease usually affects male neonates through unaffected carrier women
• The Menkes Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Menkes Disease pipeline products will significantly revolutionize the Menkes Disease market dynamics.

Menkes Disease Overview
Menkes disease (MD) is an X-linked inherited fatal infantile neurodegenerative condition. Mutations in the ATP7A gene, which transports copper throughout the body, are the cause of this inherited X-linked recessive illness. The mutation may result in preterm delivery and may cause vague symptoms including cold, hypoglycemia, and protracted jaundice.

Get a Free sample for the Menkes Disease Market Report
https://www.delveinsight.com/report-store/menkes-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Menkes Disease Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Menkes Disease Epidemiology Segmentation:
The Menkes Disease market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Menkes Disease
• Prevalent Cases of Menkes Disease by severity
• Gender-specific Prevalence of Menkes Disease
• Diagnosed Cases of Episodic and Chronic Menkes Disease

Download the report to understand which factors are driving Menkes Disease epidemiology trends @ Menkes Disease Epidemiology Forecast
https://www.delveinsight.com/sample-request/menkes-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Menkes Disease Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Menkes Disease market or expected to get launched during the study period. The analysis covers Menkes Disease market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Menkes Disease Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Menkes Disease Therapies and Key Companies
• Copper Histidinate: Cyprium Therapeutics, Inc.

Discover more about therapies set to grab major Menkes Disease market share @ Menkes Disease Treatment Market
https://www.delveinsight.com/sample-request/menkes-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Menkes Disease Market Drivers
• Submission of NDA of CUTX-101
• Increasing awareness among families who have a history of Menkes
• Parents of affected babies understand the rarity of the disease and allow their children to be a part of the trial
• Ongoing development of screening techniques
• Ongoing development of gene therapy

Menkes Disease Market Barriers
• Clinical challenges in the early diagnosis of disease
• Inability to trace the carrier mother
• Insufficient number of studies to estimate the exact number of Menkes patients
• Insufficient number of researches for the treatment of Menkes disease

Scope of the Menkes Disease Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Menkes Disease Companies: Cyprium Therapeutics, Inc., and others
• Key Menkes Disease Therapies: Copper Histidinate, and others
• Menkes Disease Therapeutic Assessment: Menkes Disease current marketed and Menkes Disease emerging therapies
• Menkes Disease Market Dynamics: Menkes Disease market drivers and Menkes Disease market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Menkes Disease Unmet Needs, KOL's views, Analyst's views, Menkes Disease Market Access and Reimbursement

To know more about Menkes Disease companies working in the treatment market, visit @ Menkes Disease Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/menkes-disease-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Menkes Disease Market Report Introduction
2. Executive Summary for Menkes Disease
3. SWOT analysis of Menkes Disease
4. Menkes Disease Patient Share (%) Overview at a Glance
5. Menkes Disease Market Overview at a Glance
6. Menkes Disease Disease Background and Overview
7. Menkes Disease Epidemiology and Patient Population
8. Country-Specific Patient Population of Menkes Disease
9. Menkes Disease Current Treatment and Medical Practices
10. Menkes Disease Unmet Needs
11. Menkes Disease Emerging Therapies
12. Menkes Disease Market Outlook
13. Country-Wise Menkes Disease Market Analysis (2019-2032)
14. Menkes Disease Market Access and Reimbursement of Therapies
15. Menkes Disease Market Drivers
16. Menkes Disease Market Barriers
17. Menkes Disease Appendix
18. Menkes Disease Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Related Reports:
Menkes Disease Epidemiology
https://www.delveinsight.com/report-store/menkes-disease-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Menkes Disease Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Menkes Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Vascular Graft Devices Market https://www.delveinsight.com/report-store/vascular-grafts-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2027 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.

Vascular Stents Market https://www.delveinsight.com/report-store/vascular-stents-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2027 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population.

Vein Illumination Devices Market https://www.delveinsight.com/report-store/vein-illumination-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2027" report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Bladder Scanners Market https://www.delveinsight.com/report-store/bladder-scanners-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's "Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2027" report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Recent Blog's By DelveInsight:
• Insights Into The Cutaneous T-cell Lymphoma Treatment Market
https://www.delveinsight.com/blog/cutaneous-t-cell-lymphoma-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Roche's HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
https://www.delveinsight.com/blog/hemlibra-for-hemophilia-a-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Emerging Role of Digital Health in the Field of Oncology
https://www.delveinsight.com/blog/digital-health-to-improve-cancer-management?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
https://www.delveinsight.com/blog/evolving-als-treatment-landscape?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• How are Technological Trends and Innovations Reshaping the Dementia Care
https://www.delveinsight.com/blog/technological-innovations-in-dementia-care?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
https://www.delveinsight.com/blog/clinical-diagnostics-market-outlook?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
https://www.delveinsight.com/blog/non-opioid-analgesics-for-chronic-pain-treatment?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
https://www.delveinsight.com/blog/alpha-1-antitrypsin-deficiency-treatment-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr
• Evaluating the Key Trends and Technologies Shaping the Future of Dentistry
https://www.delveinsight.com/blog/emerging-trends-in-dental-care-market?utm_source=blog&utm_medium=promotion&utm_campaign=gpr

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Menkes Disease Market and Epidemiology Forecast 2032: Population Data, Drugs, Companies and Competitive Intelligence by DelveInsight | Cyprium Therapeutics here

News-ID: 3249125 • Views:

More Releases from DelveInsight Business Research

Global Spasticity Therapeutics Poised for Major Evolution: DelveInsight Reveals Analysis of 12+ Pipeline Candidates
Global Spasticity Therapeutics Poised for Major Evolution: DelveInsight Reveals …
DelveInsight's newly published report, "Spasticity Pipeline Insight" delivers a comprehensive analysis of over 10 pharmaceutical and biotech companies actively developing more than 12 potential therapies across the Spasticity treatment pipeline. The report features in-depth profiles of both clinical- and preclinical-stage assets, supported by a detailed evaluation based on therapy type, stage of development, route of administration, and molecular classification. It also provides visibility into terminated and dormant programs within the
Global Advanced Melanoma Pipeline Gains Momentum With Over 60 Novel Therapies, According to DelveInsight's Report
Global Advanced Melanoma Pipeline Gains Momentum With Over 60 Novel Therapies, A …
DelveInsight's latest publication, "Advanced Melanoma Pipeline Insight," provides a comprehensive assessment of the evolving Advanced Melanoma R&D landscape, covering more than 55 pharmaceutical and biotechnology companies and over 60 pipeline candidates currently under development. The report delivers in-depth profiles of both clinical-stage and preclinical assets, alongside a detailed therapeutic evaluation categorized by product class, development phase, administration route, and molecular composition. Additionally, it highlights pipeline programs that have been paused
Geographic Atrophy Clinical Trial Analysis: 25+ Drugs, 23+ Companies Redefining the Future of Treatment, analyses DelveInsight
Geographic Atrophy Clinical Trial Analysis: 25+ Drugs, 23+ Companies Redefining …
DelveInsight's newly released report, "Geographic Atrophy Pipeline Insight" offers a comprehensive analysis of the evolving Geographic Atrophy (GA) therapeutic landscape, covering 23+ biopharmaceutical companies and 25 investigational drug candidates. The report features in-depth profiles of both clinical- and preclinical-stage assets, along with a detailed therapeutic assessment categorized by product type, development phase, route of administration, and molecular class. It also provides visibility into inactive and discontinued pipeline programs within the
Interstitial Lung Disease Clinical Trial Analysis: 120+ Drugs and 120+ Companies Advancing Next-Generation ILD Therapies, analyses DelveInsight
Interstitial Lung Disease Clinical Trial Analysis: 120+ Drugs and 120+ Companies …
DelveInsight, a prominent market intelligence and consulting organization in the life sciences domain, has announced the launch of its newest report titled "Interstitial Lung Disease Pipeline Insight, 2025." The publication delivers a comprehensive analysis of the fast-advancing therapeutic environment for Interstitial Lung Disease (ILD). With over 120 biopharmaceutical companies actively developing 120+ pipeline assets, the ILD pipeline is witnessing remarkable growth fueled by strong scientific innovation, clinical progress, and regulatory

All 5 Releases


More Releases for Menkes

Menkes Disease Market Key Drives ,Trades 2034
Market Overview The Menkes Disease Market is gaining attention as advancements in genetic diagnostics and newborn screening improve early detection of this rare, X-linked recessive disorder caused by defects in copper metabolism. Menkes disease leads to severe neurodevelopmental impairment due to dysfunctional ATP7A gene activity, making early diagnosis and timely copper histidinate treatment essential for improving survival outcomes. Although the patient population is small, rising awareness, improved clinical guidelines, and expanded
Menkes Disease Market to Witness Promising Upswing by 2034, DelveInsight Forecas …
The Key Menkes Disease Companies in the market include - Cyprium Therapeutics and Sentynl Therapeutics, Cyprium Therapeutics, Inc., and others. DelveInsight's "Menkes Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Menkes Disease, historical and forecasted epidemiology as well as the Menkes Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Menkes Disease
Menkes disease market could reach USD 400 million by 2034, growing at a 5.0% CAG …
Menkes disease, also known as hair disease, is a rare X-linked recessive genetic disorder caused by mutations in the ATP7A gene, which is responsible for copper transport. The condition leads to severe copper deficiency in the body, resulting in progressive neurodegeneration, developmental delays, connective tissue abnormalities, and distinctive brittle hair. Symptoms often present in infancy, and without treatment, the prognosis is poor, with most affected children not surviving beyond early
Menkes Disease Market Industry Overview, Market Share, and Growth Prospects Repo …
"CoherentMI has released a statistical report titled "Menkes Disease Market Recent Trends, In-depth Analysis, Size, and Forecast 2024-2031." This report offers a comprehensive overview of the competitive landscape, geographical segmentation, innovation, future developments, and a compilation of tables and data. The competitive landscape analysis provides detailed information about each vendor, encompassing company profiles, total revenue (financials), market potential, global presence, market share, pricing, locations of production facilities, and the introduction
Menkes Disease Market 2032: Epidemiology Review, Pipeline Breakthroughs, Regulat …
The Menkes Disease Market size was valued at USD 0.2 Million in the year 2021 and the report offers an in-depth understanding of the Menkes Disease, historical and forecasted epidemiology as well as the Menkes Disease market trends in the The Menkes Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Menkes Disease pipeline products will significantly revolutionize
Menkes Syndrome Market ; Investors Seeking Growth| Top Players: Fortress Biotech …
Worldwide Market Reports published a "Menkes Syndrome Market Business Growth Forecast 2023-2030" report that sheds light on the key opportunities attributing to the growth of the market. This Insight Report offers a thorough study of the global Menkes Syndrome market and identifies significant trends in product/services segmentation, company formation, revenue, market share, recent advancements, and M&A activity. With a focus on Menkes Syndrome portfolios and capabilities, market entry strategies, market